Advent Pharma Statistics

Total Valuation

Advent Pharma has a market cap or net worth of BDT 1.56 billion. The enterprise value is 1.64 billion.

Market Cap	1.56B
Enterprise Value	1.64B

Important Dates

The next estimated earnings date is Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Nov 21, 2024

Share Statistics

Advent Pharma has 93.13 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	93.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.31%
Owned by Institutions (%)	n/a
Float	44.96M

Valuation Ratios

The trailing PE ratio is 23.49.

PE Ratio	23.49
Forward PE	n/a
PS Ratio	3.00
PB Ratio	1.05
P/TBV Ratio	1.05
P/FCF Ratio	95.97
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.82, with an EV/FCF ratio of 100.38.

EV / Earnings	24.57
EV / Sales	3.13
EV / EBITDA	8.82
EV / EBIT	13.68
EV / FCF	100.38

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.05.

Current Ratio	1.41
Quick Ratio	0.89
Debt / Equity	0.05
Debt / EBITDA	0.41
Debt / FCF	4.65
Interest Coverage	14.08

Financial Efficiency

Return on equity (ROE) is 4.57% and return on invested capital (ROIC) is 4.87%.

Return on Equity (ROE)	4.57%
Return on Assets (ROA)	4.04%
Return on Capital (ROIC)	4.87%
Revenue Per Employee	1.67M
Profits Per Employee	213,511
Employee Count	312
Asset Turnover	0.28
Inventory Turnover	4.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.43%
50-Day Moving Average	17.10
200-Day Moving Average	24.07
Relative Strength Index (RSI)	47.23
Average Volume (20 Days)	691,871

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Advent Pharma had revenue of BDT 522.06 million and earned 66.62 million in profits. Earnings per share was 0.72.

Revenue	522.06M
Gross Profit	202.36M
Operating Income	119.59M
Pretax Income	81.36M
Net Income	66.62M
EBITDA	185.04M
EBIT	119.59M
Earnings Per Share (EPS)	0.72

Full Income Statement

Balance Sheet

The company has 3.92 million in cash and 75.85 million in debt, giving a net cash position of -71.93 million or -0.77 per share.

Cash & Cash Equivalents	3.92M
Total Debt	75.85M
Net Cash	-71.93M
Net Cash Per Share	-0.77
Equity (Book Value)	1.48B
Book Value Per Share	15.94
Working Capital	74.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 150.46 million and capital expenditures -134.16 million, giving a free cash flow of 16.30 million.

Operating Cash Flow	150.46M
Capital Expenditures	-134.16M
Free Cash Flow	16.30M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 38.76%, with operating and profit margins of 22.91% and 12.76%.

Gross Margin	38.76%
Operating Margin	22.91%
Pretax Margin	15.58%
Profit Margin	12.76%
EBITDA Margin	35.45%
EBIT Margin	22.91%
FCF Margin	3.12%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.60%.

Dividend Per Share	0.10
Dividend Yield	0.60%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	10.64%
Buyback Yield	n/a
Shareholder Yield	0.60%
Earnings Yield	4.26%
FCF Yield	1.04%

Dividend Details

Stock Splits

The last stock split was on February 28, 2022. It was a forward split with a ratio of 1.02.

Last Split Date	Feb 28, 2022
Split Type	Forward
Split Ratio	1.02

Scores

Advent Pharma has an Altman Z-Score of 4.67.

Altman Z-Score	4.67
Piotroski F-Score	n/a